Financhill
Buy
61

SVRA Quote, Financials, Valuation and Earnings

Last price:
$6.58
Seasonality move :
33.22%
Day range:
$6.31 - $6.58
52-week range:
$1.89 - $6.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
14.01x
Volume:
4M
Avg. volume:
2.5M
1-year change:
80.56%
Market cap:
$1.3B
Revenue:
--
EPS (TTM):
-$0.54

Analysts' Opinion

  • Consensus Rating
    Savara, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 6 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $10.31, Savara, Inc. has an estimated upside of 58.65% from its current price of $6.50.
  • Price Target Downside
    According to analysts, the lowest downside price target is $7.00 representing 100% downside risk from its current price of $6.50.

Fair Value

  • According to the consensus of 6 analysts, Savara, Inc. has 58.65% upside to fair value with a price target of $10.31 per share.

SVRA vs. S&P 500

  • Over the past 5 trading days, Savara, Inc. has overperformed the S&P 500 by 3.02% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Savara, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Savara, Inc. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Savara, Inc. reported revenues of --.

Earnings Growth

  • Savara, Inc. earnings have been falling on a year-over-year basis for 11 quarters in a row. In the most recent quarter Savara, Inc. reported earnings per share of -$0.14.
Enterprise value:
1.2B
EV / Invested capital:
9.89x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.54x
EV / Free cash flow:
-12.37x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$288K
Return On Assets:
-61.14%
Net Income Margin (TTM):
--
Return On Equity:
-78.83%
Return On Invested Capital:
-65.99%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue -- -- -- -- --
Gross Profit -$152K -$271K -$288K -$69K -$76K
Operating Income -$53.3M -$89.7M -$121.3M -$26.4M -$30.3M
EBITDA -$53.1M -$89.4M -$121M -$26.3M -$30.2M
Diluted EPS -$0.31 -$0.44 -$0.54 -$0.11 -$0.14
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $174.6M $137.1M $170.1M $226.4M $128.2M
Total Assets $187.3M $147.8M $182.1M $238.8M $140.9M
Current Liabilities $10.7M $5.2M $9M $12.8M $16.8M
Total Liabilities $32M $31.2M $35.5M $39.5M $46.5M
Total Equity $155.2M $116.5M $146.5M $199.3M $94.4M
Total Debt $25.7M $26M $26.3M $26.6M $29.8M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$44.1M -$81.4M -$99.3M -$22.7M -$22.5M
Cash From Investing -$122.9M -$51.3M $93M -$98.2M $21.5M
Cash From Financing $74.9M $126.3M $1.4M $118.3M -$23K
Free Cash Flow -$44.4M -$81.5M -$99.3M -$22.7M -$22.5M
SVRA
Sector
Market Cap
$1.3B
$28.5M
Price % of 52-Week High
98.41%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
0.05%
-1.33%
1-Year Price Total Return
80.56%
-20.32%
Beta (5-Year)
0.226
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $5.95
200-day SMA
Buy
Level $3.17
Bollinger Bands (100)
Buy
Level 2.77 - 4.61
Chaikin Money Flow
Sell
Level -83.1M
20-day SMA
Buy
Level $5.02
Relative Strength Index (RSI14)
Buy
Level 77.28
ADX Line
Buy
Level 52.24
Williams %R
Sell
Level -4.2683
50-day SMA
Buy
Level $4.30
MACD (12, 26)
Buy
Level 0.61
25-day Aroon Oscillator
Buy
Level 68
On Balance Volume
Neutral
Level 241.6M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.9052)
Sell
CA Score (Annual)
Level (-1.4778)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (3.3606)
--
Piotroski F Score (Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (2)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.

Stock Forecast FAQ

In the current month, SVRA has received 6 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SVRA average analyst price target in the past 3 months is $10.31.

  • Where Will Savara, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Savara, Inc. share price will rise to $10.31 per share over the next 12 months.

  • What Do Analysts Say About Savara, Inc.?

    Analysts are divided on their view about Savara, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Savara, Inc. is a Sell and believe this share price will drop from its current level to $7.00.

  • What Is Savara, Inc.'s Price Target?

    The price target for Savara, Inc. over the next 1-year time period is forecast to be $10.31 according to 6 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is SVRA A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Savara, Inc. is a Buy. 6 of 6 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of SVRA?

    You can purchase shares of Savara, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Savara, Inc. shares.

  • What Is The Savara, Inc. Share Price Today?

    Savara, Inc. was last trading at $6.58 per share. This represents the most recent stock quote for Savara, Inc.. Yesterday, Savara, Inc. closed at $6.50 per share.

  • How To Buy Savara, Inc. Stock Online?

    In order to purchase Savara, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
50
TGL alert for Dec 8

Treasure Global, Inc. [TGL] is up 21.86% over the past day.

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 39.76% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 7.15% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock